X-linked Alport syndrome presenting in mother and son with the same unique histopathological features.

COL4A5 Alport syndrome Bowman’s capsule Collagen assembly IgA nephropathy

Journal

Journal of nephrology
ISSN: 1724-6059
Titre abrégé: J Nephrol
Pays: Italy
ID NLM: 9012268

Informations de publication

Date de publication:
26 Apr 2024
Historique:
received: 29 12 2023
accepted: 24 03 2024
medline: 26 4 2024
pubmed: 26 4 2024
entrez: 26 4 2024
Statut: aheadofprint

Résumé

Alport syndrome has been linked to three different genes, that is, COL4A3, COL4A4 and COL4A5. It is characterized by progressive and non-specific glomerulosclerosis with irregular thickening of the glomerular basement membrane (GBM). At times, the histopathologic picture is dominated by lesions that are consistent with focal and segmental glomerulosclerosis or IgA nephropathy. Here, we report the cases of two related individuals (mother and son) who were diagnosed with COL4A5-related Alport syndrome due to a missense variant (p.Gly1170Ser) in a G-X-Y repeat and found to present the same highly unusual histopathological abnormalities on their kidney biopsies. One of the abnormalities shared, which does not appear to have been reported, was reduced COL4A5 immunolabeling that was limited to Bowman's capsule even though the ultrastructure of the GBM was distorted. The other abnormality was superimposed segmental IgA deposition in both individuals, accompanied by mesangial changes in the mother. We feel that these findings provide novel insight into the mechanisms of disease manifestation in Alport syndrome. They suggest, in particular, that collagen expression and/or assemblies in Bowman's capsule is more vulnerable to missense mutations in COL4A5 than elsewhere in the kidney. Our findings also suggest that certain coinherited gene polymorphisms act as unexpectedly important phenotypic determinants in COL4A-related disorders.

Identifiants

pubmed: 38668984
doi: 10.1007/s40620-024-01942-7
pii: 10.1007/s40620-024-01942-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Kidney Foundation of Canada
ID : Biomedical Research
Organisme : Canadian Institutes of Health and Research
ID : Grant Project

Informations de copyright

© 2024. The Author(s).

Références

Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG (2003) Alport’s syndrome, Goodpasture’s syndrome, and type IV collagen. N Engl J Med. https://doi.org/10.1056/NEJMra022296
doi: 10.1056/NEJMra022296 pubmed: 12917300
Nozu K, Nakanishi K, Abe Y et al (2019) A review of clinical characteristics and genetic backgrounds in Alport syndrome. Clin Exp Nephrol 23(2):158–168. https://doi.org/10.1007/s10157-018-1629-4
doi: 10.1007/s10157-018-1629-4 pubmed: 30128941
Savige J, Harraka P (2021) Pathogenic variants in the genes affected in Alport syndrome (COL4A3-COL4A5) and their association with other kidney conditions: a review. Am J Kidney Dis. https://doi.org/10.1053/j.ajkd.2021.04.017
doi: 10.1053/j.ajkd.2021.04.017 pubmed: 34245817
Gast C, Pengelly RJ, Lyon M et al (2016) Collagen (COL4A) mutations are the most frequent mutations underlying adult focal segmental glomerulosclerosis. Nephrol Dial Transplant 31(6):961–970. https://doi.org/10.1093/ndt/gfv325
doi: 10.1093/ndt/gfv325 pubmed: 26346198
Hashimura Y, Nozu K, Kaito H et al (2014) Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV α5 chain. Kidney Int 85(5):1208–1213. https://doi.org/10.1038/ki.2013.479
doi: 10.1038/ki.2013.479 pubmed: 24304881
Gross O, Netzer KO, Lambrecht R, Seibold S, Weber M (2002) Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling. Nephrol Dial Transplant 17(7):1218–1227. https://doi.org/10.1093/ndt/17.7.1218
doi: 10.1093/ndt/17.7.1218 pubmed: 12105244
Li Y, Groopman EE, D’Agati V et al (2020) Type IV collagen mutations in familial IgA nephropathy. Kidney Int Rep 5(7):1075–1078. https://doi.org/10.1016/j.ekir.2020.04.011
doi: 10.1016/j.ekir.2020.04.011 pubmed: 32647767 pmcid: 7335950
Paterson AD, Liu XQ, Wang K et al (2007) Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility locus to chromosome 2q36. J Am Soc Nephrol 18(8):2408–2415. https://doi.org/10.1681/asn.2007020241
doi: 10.1681/asn.2007020241 pubmed: 17634434
Zhou X, Khan S, Huang D, Li L (2022) V-Set and immunoglobulin domain containing (VSIG) proteins as emerging immune checkpoint targets for cancer immunotherapy. Front Immunol 13:938470. https://doi.org/10.3389/fimmu.2022.938470
doi: 10.3389/fimmu.2022.938470 pubmed: 36189222 pmcid: 9520664

Auteurs

Nicolas A D Bergeron (NAD)

Service of Nephrology, L'Hôtel-Dieu de Québec Research Center, CHU de Québec-Université Laval, 10 McMahon Street (Room 3852), Québec, QC, G1R 2J6, Canada.

Alexandre P Garneau (AP)

Service de Néphrologie-Transplantation Rénale Adultes, Hôpital Necker-Enfants Malades, AP-HP, Inserm U1151, Université Paris Cité, Rue de Sèvres, Paris, France.

Mathieu Rousseau-Gagnon (M)

Service of Nephrology, L'Hôtel-Dieu de Québec Research Center, CHU de Québec-Université Laval, 10 McMahon Street (Room 3852), Québec, QC, G1R 2J6, Canada.

Julie Riopel (J)

Service of Pathology, CHU de Québec-Université Laval, Québec, QC, G1R 2J6, Canada.

Paul Isenring (P)

Service of Nephrology, L'Hôtel-Dieu de Québec Research Center, CHU de Québec-Université Laval, 10 McMahon Street (Room 3852), Québec, QC, G1R 2J6, Canada. paul.isenring@crhdq.ulaval.ca.

Classifications MeSH